- Other Post Graduate Training - UT Southwestern Medical School (1996-2005)
- Graduate School - UT Southwestern Medical School (1996-2005)
- Fellowship - Dana-Farber Cancer Institute (2007-2011), Hematology Oncology
- Residency - Massachusetts General Hospital (2005-2007), Internal Medicine
- Medical School - UT Southwestern Medical School (1996-2005)
Deepak Nijhawan, M.D., Ph.D.
- UT Southwestern Presidential Scholar
- Joseph F. Sambrook, Ph.D. Distinguished Chair in Biomedical Science
- Radiation Oncology
- Lung Cancer
Biography
Dr. Nijhawan is originally from Chicago and completed the medical scientist training program at UT Southwestern in 2005. He then completed a residency in Internal Medicine and clinical fellowship in Medical Oncology before returning to UT Southwestern.
He is interested in using cancer genomics to predict new cancer vulnerabilities. During his fellowship, he used functional cancer genomics to identify novel targets in cancer. He developed a novel strategy to target “passenger” genes as an Achilles heel in ovarian cancer.
At UTSW, he is interested in expanding the list of vulnerabilities and translating these findings into the clinic to improve the treatment of ovarian and lung cancer. Dr. Nijhawan’s interests outside of medicine include cycling, hiking, travel, and sports.
Education & Training
Professional Associations & Affiliations
- Conquer Cancer Foundation (2007)
- American Association of Cancer Research (2007)
Honors & Awards
- ASCO Young Investigator Award 2007
Books & Publications
-
Publications
-
Elimination of Mcl-1 is required for the initiation of apoptosis following ultravioet irradiation
Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F, Wang X 2003 17 1475-86 -
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex intitates an apoptotic protease cascade
Li, P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X 1997 91 479-489
-
Elimination of Mcl-1 is required for the initiation of apoptosis following ultravioet irradiation
Research
- Synthetic Lethality
- Lung Cancer
- Chemical Target Identification
- Cancer Genomics
Clinical Focus
- Lung Cancer